MD1505G2 - Preparat pentru tratamentul afecţiunilor reumatoide - Google Patents

Preparat pentru tratamentul afecţiunilor reumatoide Download PDF

Info

Publication number
MD1505G2
MD1505G2 MD99-0282A MD990282A MD1505G2 MD 1505 G2 MD1505 G2 MD 1505G2 MD 990282 A MD990282 A MD 990282A MD 1505 G2 MD1505 G2 MD 1505G2
Authority
MD
Moldova
Prior art keywords
rheumatoid
affections
treatment
preparation
immunoglobulin
Prior art date
Application number
MD99-0282A
Other languages
English (en)
Russian (ru)
Other versions
MD1505F1 (ro
Inventor
Генадие МОРДВИНОВ
Original Assignee
Генадие МОРДВИНОВ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Генадие МОРДВИНОВ filed Critical Генадие МОРДВИНОВ
Priority to MD99-0282A priority Critical patent/MD1505G2/ro
Publication of MD1505F1 publication Critical patent/MD1505F1/ro
Publication of MD1505G2 publication Critical patent/MD1505G2/ro

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Invenţia se referă la medicină şi este destinată tratamentului bolnavilor cu afecţiuni reumatoide.Preparatul pentru tratamentul afecţiunilor reumatoide conţine imunoglobulină G umană agregată în formă de soluţie apoasă de 10%.Rezultatul invenţiei constă în inhibarea sintezei factorului reumatoid.
MD99-0282A 1999-12-17 1999-12-17 Preparat pentru tratamentul afecţiunilor reumatoide MD1505G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD99-0282A MD1505G2 (ro) 1999-12-17 1999-12-17 Preparat pentru tratamentul afecţiunilor reumatoide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD99-0282A MD1505G2 (ro) 1999-12-17 1999-12-17 Preparat pentru tratamentul afecţiunilor reumatoide

Publications (2)

Publication Number Publication Date
MD1505F1 MD1505F1 (ro) 2000-07-31
MD1505G2 true MD1505G2 (ro) 2001-01-31

Family

ID=19739503

Family Applications (1)

Application Number Title Priority Date Filing Date
MD99-0282A MD1505G2 (ro) 1999-12-17 1999-12-17 Preparat pentru tratamentul afecţiunilor reumatoide

Country Status (1)

Country Link
MD (1) MD1505G2 (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3144G2 (ro) * 2006-04-03 2007-04-30 Генадие МОРДВИНОВ Remediu pentru tratamentul artritei reumatoide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1226G2 (ro) * 1998-10-06 1999-10-31 Генадие МОРДВИНОВ Preparat pentru tratamentul afecţiunilor reumatoide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1226G2 (ro) * 1998-10-06 1999-10-31 Генадие МОРДВИНОВ Preparat pentru tratamentul afecţiunilor reumatoide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Combe B., Cosso B., Clot J., Bonneau N., Sany J. Human placenta-eluted gammaglobulins in immunomodulating treatment of rheumatoid arthritis. Am. J. Med., 1985, nr. 78, p. 920-928 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3144G2 (ro) * 2006-04-03 2007-04-30 Генадие МОРДВИНОВ Remediu pentru tratamentul artritei reumatoide

Also Published As

Publication number Publication date
MD1505F1 (ro) 2000-07-31

Similar Documents

Publication Publication Date Title
HUP9902105A2 (hu) Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
DE69721766D1 (de) Neue arzneiformulierung
SI1296633T1 (sl) Omot medicinskega izdelka za eradikacijsko zdravljenje
ATE326867T1 (de) Freie aminosäure enthaltende zusammensetzung
ATE141792T1 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson- syndromen
NZ514077A (en) Treatment of Α-galactosidase A deficiency
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
MY164077A (en) Compositions and uses of et743 for treating cancer
GR3035402T3 (en) Use of incense in the treatment of alzheimer's disease
ATE219670T1 (de) Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia
DE59609099D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
KR950031063A (ko) 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
WO2001089537A3 (en) Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
BR0009380A (pt) Tratamento de câncer melhorado comtemozolomida
HUP9903213A1 (en) Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease and the medicament itself
MD1505F1 (ro) Preparat pentru tratamentul afectiunilor reumatoide
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
KR100271087B1 (en) Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
MD1226F1 (ro) Preparat pentru tratamentul afectiunilor reumatoide
UA41652A (uk) Спосіб лікування хворих на гіпертонічну хворобу

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees